- Fellowship - Vanderbilt University School of Medicine (1980-1982), Gastroenterology
- Fellowship - Johns Hopkins Hospital (1979-1980), Hepatology
- Residency - Johns Hopkins Hospital (1977-1979), Internal Medicine
- Medical School - Johns Hopkins University School of Medicine (1973-1977)

Mack Mitchell, M.D.
Vice President Medical Affairs
- Nancy S. and Jeremy L. Halbreich Professorship in Gastroenterology
- Internal Medicine - Digestive and Liver Diseases
- Liver Disease
- Esophageal Disorders
New Patient Appointment Accepting Virtual Visits or 214-645-8300
Biography
Mack Mitchell, M.D., a Professor of Internal Medicine, is the UT Southwestern Vice President for Medical Affairs. He is also the Chief Medical Officer for the Southwestern Health Resources Physician Network. Dr. Mitchell’s clinical expertise is in gastroenterology and liver diseases, and his research has been focused on alcoholism.
He earned his medical degree at Johns Hopkins University School of Medicine, where he was elected to Alpha Omega Alpha, and he has been listed repeatedly as one of D Magazine’s Best Doctors in Dallas.
Before coming to UT Southwestern, Dr. Mitchell was the Chief of Gastroenterology and the Medical Director of Ambulatory Services at Johns Hopkins Bayview Medical Center; the Chairman of Internal Medicine at Greater Baltimore Medical Center; and the Chairman of Medicine at Carolinas Medical Center in Charlotte, North Carolina.
He is currently President of ABMRF/The Foundation for Alcohol Research, and was recently honored with the Seixas Award for Distinguished Service by the Research Society on Alcoholism.
Education & Training
Honors & Awards
- Research Society on Alcoholism 2007, Seixas Award for Distinguished Service
Books & Publications
-
Publications
-
Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis.
Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL Alcoholism, clinical and experimental research 1990 Apr 14 2 -
Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease.
Jia L, Chang X, Qian S, Liu C, Lord CC, Ahmed N, Lee CE, Lee S, Gautron L, Mitchell MC, Horton JD, Scherer PE, Elmquist JK Molecular metabolism 2018 May -
Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis.
Saha B, Tornai D, Kodys K, Adejumo A, Lowe P, McClain C, Mitchell M, McCullough A, Dasarathy S, Kroll-Desrosiers A, Barton B, Radaeva S, Szabo G, Hepatology (Baltimore, Md.) 2019 10 70 4 1134-1149 -
Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis.
Vatsalya V, Cave MC, Kong M, Gobejishvili L, Falkner KC, Craycroft J, Mitchell M, Szabo G, McCullough A, Dasarathy S, Radaeva S, Barton B, McClain CJ, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Aug 18 9 2046-2054 -
Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.
Dasarathy S, Mitchell MC, Barton B, McClain CJ, Szabo G, Nagy LE, Radaeva S, McCullough AJ, Contemporary clinical trials 2020 Jul 96 106094 -
Changes in plasma amino acids during sobriety in alcoholic patients with and without liver disease.
Diehl AM, Mitchell MC, Herlong HF, Potter JJ, Wacker L, Mezey E The American journal of clinical nutrition 1986 Oct 44 4 -
Diagnostic and Prognostic Significance of Complement in Patients with Alcohol-associated Hepatitis.
Fan X, McCullough RL, Huang E, Bellar A, Kim A, Poulsen KL, McClain CJ, Mitchell M, McCullough AJ, Radaeva S, Barton B, Szabo G, Dasarathy S, Rotroff DM, Nagy LE, Hepatology (Baltimore, Md.) 2020 Jun -
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.
Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G Gastroenterology 2016 Feb
-
Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis.
Clinical Focus
- Liver Disease
- Esophageal Disorders
- Gastroenterology
- Liver Transplant Medicine
- Cancer Screening
- Gastroduodenal Diseases
Results: 1 Locations
Digestive Disease Clinic
at Outpatient Building 1801 Inwood Road, 6th Floor, Suite 102Dallas, Texas 75390 214-645-0595 Directions to Digestive Disease Clinic Parking Info for Digestive Disease Clinic
New Patient Appointment Accepting Virtual Visits or 214-645-8300 or 817-882-2400